Could cannabis ease cancer symptoms in kids? new trial aims to find out

NCT ID NCT05754840

Recruiting now Symptom relief Sponsor: University of Manitoba Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This Canadian study is testing whether cannabinoid oils (CBD and THC) can safely help manage symptoms like pain in children aged 4-17 with relapsed or refractory cancer. The trial will enroll 60 kids across three hospitals, giving them different ratios of CBD to THC oils to see which is best tolerated. The goal is to find a safe way to improve quality of life during cancer treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: cannabinoid oils (CBD and THC combinations)
What this could lead to: If it works, this could point toward a safe way to manage pain and other symptoms in children with cancer, improving their quality of life.
What could go wrong: This is an early-phase trial with only 60 participants, so results may not apply to all children. Side effects from cannabinoids are possible, and the study focuses on tolerability, not yet on proven effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer cannabis dependence childhood malignant neoplasm neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER CHILDHOOD CANCER

Contacts and locations

Locations

BC Children's Hospital
RECRUITING

Vancouver, British Columbia, V6H 3N1, Canada
IWK Health Centre
RECRUITING

Halifax, Nova Scotia, B3K 6R8, Canada
The Hospital for Sick Children
RECRUITING

Toronto, Ontario, M5G 1X8, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.